Sensitive and selective spectrophotometric assay of rizatriptan benzoate in pharmaceuticals using three sulphonphthalein dyes

Arabian Journal of Chemistry

Volumn 9, Issue , 2016, Pages S971-S980

  Prashanth, K N ^a   Basavaiah, K ^a   Vinay, K B ^a  

^a UNIVERSITY OF MYSORE   (India)

Author keywords

Ion pair complex; Pharmaceuticals; Rizatriptan benzoate assay; Spectrophotometry; Sulphonphthalein dyes

Indexed keywords

CHLORINE COMPOUNDS; DRUG PRODUCTS; DYES; IONS; SPECTROPHOTOMETERS;

ACCURACY AND PRECISION; BROMOCRESOL PURPLES; CONCENTRATION RANGES; METHOD VALIDATIONS; RIZATRIPTAN BENZOATES; SPECTRO-PHOTOMETRIC METHOD; SPECTROPHOTOMETRIC ASSAYS; STATISTICAL COMPARISONS;

SPECTROPHOTOMETRY;

EID: 80355134541     PISSN: 18785352     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arabjc.2011.10.006     Document Type: Article

References (30)

1. Abdine, H., Belal, F., Zoman, N., Simple spectrophotometric determination of cinnarizine in its dosage forms. IL Farmaco 57:4 (2002), 267–271.
2. Al-Ghannam, S.M., A simple spectrophotometric method for the determination of beta-blockers in dosage forms. J. Pharm. Biomed. Anal. 40 (2006), 151–156.
3. Altinoz, S., Ucar, G., Yıldız, E., Determination of rizatriptan in its tablet dosage forms by UV spectrophotometric and spectrofluorimetric methods. Anal. Lett. 35:15 (2002), 2471–2485.
4. Amol, K., Vivek, R., Alpana, K., Hassan, D.M., Maria, S., Swaroop, L., Spectrophotometric method for analysis of rizatriptanbenzoate. Int. J. Pharm. Sci. 1:2 (2009), 307–309.
5. Ashour, S., Bayram, R., Chehna, F.M., Spectrophotometric determination of alfuzosin HCl in pharmaceutical formulations with some sulphonephthalein dyes. Int. J. Biomed. Sci. 2:3 (2006), 273–278.
6. Basavaiah, K., Sameer, A.M.A., Vinay, K.B., Simple and sensitive spectrophotometric determination of olanzapine in pharmaceutical formulations using two sulphonphthalein acid dyes. J. Food Drug Anal. 17:6 (2009), 434–442.
7. Chen, J., Jiang, X., Jiang, W., Mei, N., Gao, X., Zhang, Q., Liquid chromatographic method for the determination of rizatriptan in human plasma. J. Chromatogr. B 805 (2004), 169–173.
8. Chen, Y., Miao, H., Lin, M., Fan, G., Honga, Z., Wu, H., Wu, Y., Development and validation of a selective and robust LC–MS/MS method for high-throughput quantifying rizatriptan in small plasma samples: Application to a clinical pharmacokinetic study. J. Chromatogr. B 844 (2006), 268–277.
9. Dannana Gowry, S., Marothu Vamsi, K., Visible spectrophotometric methods for the determination of rizatriptan in pure form and in pharmaceutical formulations. Anal. Chem. An Indian J. 3 (2007), 4–6.
10. Douglas, A.S., Donald, M.W., Principles of Instrumental Analysis. 1971, Holt, Rinehart, Winston, New York.
11. Erk, N., Extractive spectrophotometric methods for the novel antidepressant drug in bulk and pharmaceutical dosage forms by using bromothymol blue and bromcresol green. Anal. Lett. 36 (2003), 1183–1196.
12. 1B/1D receptor agonists in migraine: comparative pharmacology and its therapeutic implications. CNS Drugs 10 (1998), 271–286.
13. Gory, S., Slorelli, N., Bellini, G., Bonanni, E., Manaca, L., Orlandi, G., Ludice, A., Murri, L., Rizatriptan does not change cerebral blood flow velocity during migraine attacks. Brain Res. Bull. 65 (2005), 297–300.
14. Guo, J., Zhang, A., Zhao, L., Sun, X., Zhao, Y., Gao, H., Liu, Z., Qiao, S., Determination of rizatriptan in human plasma by liquid chromatographic–eletrospray tandem mass spectrometry: application to a pharmacokinetic study. Biomed. Chromatogr. 20:1 (2006), 61–66.
15. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R 1), Complementary Guideline on Methodology dated 06 November 1996, incorporated in November 2005, London.
16. Jocic, B., Zecevic, M., Zivanovic, Lj., Licanski, A., A chemometrical approach to optimization and validation of an HPLC assay for rizatriptan and its impurities in tablets. Anal. Lett. 40 (2007), 2301–2316.
17. Kumari, A.S., Subhasish, S., Kaushik, D.K., Annapurna, M.M., UV-spectroscopic methods for estimation of rizatriptan benzoate in pharmaceutical preparations. Int. J. Chem. Tech. Res. 2:1 (2010), 653–659.
18. Mahuzier, P.E., Clark, B.J., Crumpton, A.J., Kevin, D.A., Quantitative microemulsion electrokinetic capillary chromatography analysis of formulated drug products. J. Sep. Sci. 24 (2001), 784–788.
19. Manjunatha, D.H., Shaikh, S.M.T., Harikrishna, K., Sudhirkumar, R., Kandagal, P.B., Seetharamappa, J., Simple and sensitive spectrophotometric methods for the determination of acebutolol hydrochloride in bulk sample and pharmaceutical preparations. Ecl. Quím. 33:2 (2008), 37–40.
20. Oldman, A.D., Smith, L.A., McQuay, H.S., Moore, R.A., Pharmacological treatments for acute migraine: quantitative systematic review. Pain 97 (2002), 247–257.
21. Qin, Y.P., Zou, Y.G., Liang, M.Z., Yu, Q., Determination of rizatriptan in human plasma by RP-HPLC with fluorescence detection. Yaowu Fenxi Zazhi 26:1 (2006), 7–9.
22. Ramzia, I.El-B., Nashwah, G.M., Heba, A., Fluorimetric and colorimetric methods for the determination of some antimigraine drugs. J. Chem. Pharm. Res. 3:4 (2011), 304–314.
23. Sagar, P.V., Kumar, D., Suddhasattya, D., Samal, H.B., Simultaneous estimation of rizatriptan, sumatriptan and zolmitriptan by RP-HPLC method in bulk. J. Pharm. Res. 3:12 (2010), 2930–2933.
24. Shahdousti, P., Aghamohammadi, M., Alizadeh, N., Spectrophotometric study of the charge-transfer and ion-pair complexation of methamphetamine with some acceptors. Spectrochim. Acta Part A 69:4 (2008), 1195–1200.
25. Shanmukha Kumar, J.V., Ramachandran, D., Settaluri, V.S., Lakshmi, L.A., Shechinah, F.C., Validation of analytical procedures for determination of rizatriptan benzoate. Pharm. Res. 4 (2010), 28–37.
26. Shanmukha Kumar, J.V., Prasad, K.R.S., Ramachandran, D., Settaluri, V.S., Development and validation of spectrophotometric methods for determination of maxalt (rizatriptan benzoate) in pure and pharmaceutical formulation. IJPI's J. Anal. Chem. 1:5 (2011), 1–5.
27. Vishwanathan, K., Bartlett, M.G., Stewart, J.T., Determination of antimigraine compounds rizatriptan, zolmitriptan, naratriptan and sumatriptan in human serum by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun. Mass Spectrom. 14:3 (2000), 168–172.
28. Vivek, R., Amol, K., Alpana, K., Hassan, D.M., Maria, S., Swaroop, L., Spectrophotometric estimation of rizatriptan benzoate. Asian J. Res. Chem. 03:01 (2010), 175–177.
29. Williamson, D.J., Shepheard, S.L., Hill, R.G., Hargreaves, R.J., The novel antimigraine agent rizatriptan inhibits neurogenic dual vasodilation and extravasation. Eur. J. Pharmacol. 328 (1997), 61–64.
30. Zecevic, M., Jocic, B., Zivanovic, L., Protic, A., Application of multicriteria methodology in the development of improved RP-LC-DAD for determination of rizatriptan and its degradation products. Chromatographia 68:11-12 (2008), 911–918.